Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Aemetis reported a significant revenue increase to $88.2 million for Q3 2026, achieving a net income of $5.2 million compared to a net loss of $23.7 million in the prior year period. The company is expanding its California Dairy Renewable Natural Gas operations, recently placing two new anaerobic digesters into service and increasing its biogas collection pipeline network.
Dogwood Therapeutics reported third quarter 2026 financial results, highlighting the completion of its Halneuron Phase 2b trial for chemotherapy-induced neuropathic pain with top-line results expected in November 2026. The company also closed a $5 million private placement with Sealbond Limited to fund Phase 3 preparatory activities, extending its cash runway into the first quarter of 2027.
Term
3 months
“With results from the recently completed Phase 2b CINP study to be reported in November, we believe that if successful, Halneuron® could represent the first new therapeutic agent for millions of CINP patients in the US and tens of millions of CINP patients across the globe.”
Greg Duncan, Chief Executive Officer of Dogwood Therapeutics
Taha Kass-Hout notified GE HealthCare Technologies Inc. of his resignation as Chief Science and Technology Officer on November 4, 2026. His departure is effective December 31, 2026.
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on hematologic diseases, reporting as a large accelerated filer with 45,540,842 shares of common stock outstanding as of October 29, 2026. The company continues to incur significant net losses, has no products approved for commercial sale, and anticipates the need for substantial additional funding to support its clinical development programs, including bitopertin.
ChoiceOne Financial Services filed a formal investor presentation deck to be used by management in meetings with investors beginning November 5, 2026. The presentation provides a company overview, highlighting $4.5 billion in total assets and its strategic vision to be the best bank in Michigan.
Oncor reported Q3 2026 net income of $572 million, a significant increase from $380 million in the prior year, driven by new base rates and higher customer consumption due to warmer weather. The company deployed $6.3 billion in capital through the first nine months of the year and remains on track for a record $9.0 billion annual capital investment plan to support Texas' growing energy infrastructure needs.
“Texas’ continued economic growth depends on having the electric infrastructure in place to reliably serve its communities and businesses. I want to thank the Oncor team for their continued commitment to safely and reliably serving our customers and for the important work underway to help strengthen the grid for Texas’ future. We look forward to working with lawmakers, regulators, landowners, and other stakeholders across Texas to advance the infrastructure needed to meet the state’s growing energy needs.”
Playtika Holding Corp. reported revenues of $673.8 million for the third quarter of 2026, nearly flat compared to the prior year. While income from operations for the quarter increased to $116.2 million, the nine-month performance showed a decline in operating income from $275.9 million in 2025 to $201.2 million in 2026, primarily driven by higher general and administrative expenses.
For the nine months ended September 30, 2026, MACERICH CO reported a net loss attributable to the company of $80.2 million, an improvement from the $178.4 million loss in the prior year period. Total revenues remained relatively flat at $751.3 million, while the company significantly strengthened its cash position to $560.8 million and reduced mortgage notes payable by approximately $659 million.
Local Bounti Corporation received a nine-month extension from the NYSE to regain compliance with the minimum market capitalization and stockholders' equity standards. The company now has until August 5, 2027, to achieve a 30-day average market capitalization or stockholders' equity of at least $50 million.
Liberty Media entered into an exchange agreement with John C. Malone to acquire 2,316,537 shares of high-vote Series B common stock in exchange for Series A and Series C shares. The transaction reduces Malone's voting power from approximately 48% to 3%, aligning his voting influence more closely with his economic interest and preventing a potential transfer of voting control to a third party.
ScanSource reported net sales of $962.3 million for the quarter ended September 30, 2026, a significant increase from $739.7 million in the prior year, though net income decreased to $8.7 million from $19.9 million. The company's balance sheet reflects a substantial increase in goodwill and intangible assets, alongside new borrowings of $231.9 million under its revolving credit facility.
Disc Medicine reported Q3 2026 financial results and provided a corporate update, highlighting the successful Phase 3 APOLLO trial of bitopertin which met all primary and secondary endpoints. The company plans to resubmit its NDA for bitopertin by year-end 2026 and recently strengthened its balance sheet with a $486 million public offering in October, extending its cash runway into 2030.
“In our first pivotal trial readout as a company, APOLLO delivered strong and compelling evidence of the potential clinical benefit of bitopertin for patients with EPP. We look forward to engaging with regulators with the goal of bringing an important, innovative medicine to this community as efficiently as possible.”
John Quisel, J.D., Ph.D., President and Chief Executive Officer
“Alongside our anticipated end-of-Phase 2 FDA meeting for selcodebart in anemia of myelofibrosis in the fourth quarter and a strengthened balance sheet, we are well positioned to support the anticipated launch of bitopertin and advance two additional programs toward pivotal-stage development in 2027.”
John Quisel, J.D., Ph.D., President and Chief Executive Officer
Perma-Fix Environmental Services reported Q3 2026 financial results, highlighting a 39% sequential revenue increase and a 25% growth in treatment backlog to $19.6 million. The company noted increased activity at its Perma-Fix Northwest facility related to the Hanford DFLAW program and improved margins in its Services Segment.
Term
3 months ended September 30, 2026
“Our third quarter results reflect meaningful improvement over the first half of the year. Revenue increased 39% sequentially from second quarter of 2026, consolidated gross profit returned to positive territory and our net loss decreased from the second quarter.”
Novelis delivered 20% EBITDA growth despite operational headwinds, focusing on the Bay Minette commissioning and aggressive cost-cutting to offset $78 million in tariff impacts and labor strikes.
Aptevo Therapeutics announced a clinical milestone for mipletamig in frontline AML, achieving a substantial reduction in infusion-related reactions (IRRs) through a refined priming-dose regimen. This optimization, identified through FDA discussions, improves patient tolerability in the ongoing RAINIER study as the company prepares for Phase 2 development.
“We have made substantial progress in improving mipletamig’s tolerability for patients with frontline AML. Mipletamig has demonstrated a differentiated safety and tolerability profile, and successive refinements to the priming-dose regimen have substantially reduced the occurrence of infusion-related reactions. Reducing these reactions matters to patients: it has the potential to make treatment easier to tolerate and limit complications that can disrupt care. These findings are an important part of our preparations for the next stage of clinical development.”
Dirk Huebner, M.D., Chief Medical Officer of Aptevo Therapeutics
TheRealReal, Inc. has appointed Sharmistha Dubey, the former CEO of Match Group, to its Board of Directors as a Class II Director. The Board was expanded from seven to eight members to accommodate the appointment, and Ms. Dubey will receive an annual compensation package consisting of a $35,000 cash retainer and $165,000 in restricted stock units.
MDU Resources reported third quarter 2026 net income of $14.0 million, or $0.07 per share, while reaffirming its full-year earnings guidance. The company also announced a positive final investment decision for the Bakken East Pipeline, a major infrastructure project with an estimated capital investment of $2.8 billion to $3.1 billion.
“We continued to execute our CORE strategy during the third quarter, with strong performance from our electric utility while advancing significant investments that are designed to support growing energy needs and long-term value creation.”
Nicole A. Kivisto, president and CEO of MDU Resources
“Our employees are the foundation of our ability to safely and reliably serve customers while advancing these growth opportunities. They operate and maintain the systems that serve our customers while working to meet the evolving energy needs of our communities.”
Nicole A. Kivisto, president and CEO of MDU Resources
ScanSource reported Q1 fiscal 2027 financial results with net sales increasing 30.1% year-over-year to $962.3 million, driven by strong demand and the acquisition of MicroAge. Despite top-line growth, GAAP diluted EPS fell to $0.42 from $0.89 in the prior year, impacted by sales mix and higher bad debt expense in Brazil.
Term
Q1 2027
“Top-line demand was strong this quarter, and we grew net sales and gross profit in both segments. We’re executing our strategy and expanding our total addressable market. In September, we closed the MicroAge acquisition, which enhances our solution capabilities and aligns with our 3-year strategic goals.”
CION Investment Corp reported Q3 2026 financial results, including net investment income of $0.25 per share and a net asset value of $13.20 per share. The company also declared base distributions totaling $0.25 per share for the first quarter of 2027 and successfully completed a deleveraging strategy by repaying its JPM Credit Facility and Series A Senior Unsecured Notes.
Investors Title Company reported Q3 2026 net income of $9.4 million on revenues of $81.9 million, which grew 12.1% year-over-year. The revenue growth was driven by higher real estate transaction volumes and title insurance premiums, though earnings were impacted by net investment losses and higher claims provisions.
Term
Q3 2026
“We are pleased with the growth in title insurance revenues and continued ongoing initiatives. While higher claims experience and investment-related volatility decreased quarterly earnings, our underlying business continued to perform well, contributing to solid year-to-date results.”
MarketWise reported Q3 2026 financial results with billings increasing 27% year-over-year to $80.7 million and net income of $15.1 million. The company reaffirmed its full-year 2026 billings target of $330 million and cash flow from operations target of $50 million while maintaining its $1.80 per share annual dividend target.
Term
Q3 2026
“The operational momentum and strong growth continued into the third quarter as Q3 Billings increased 27% year over year due to higher customer acquisition in Q1 and Q2, improved customer retention, and strong conversion of our higher priced products”
Dr. David Eifrig, Chief Executive Officer
“Our performance for the year is largely playing out as we expected. As previously mentioned, for the first and second quarters, we meaningfully increased investment in customer acquisition. This opportunistic marketing investment resulted in a strong increase in Paid Subscribers during the first half of the year.”
MarketWise, Inc. reported total net revenue of $80.1 million for the third quarter of 2026, a slight decrease from $81.3 million in the prior year period. Net income for the quarter was $15.1 million, down from $17.9 million, while year-to-date income from operations saw a significant decline from $49.4 million in 2025 to $10.5 million in 2026 due to increased sales and marketing and general and administrative expenses.
For the nine months ended September 30, 2026, NeoNc Technologies reported a net loss of $27.5 million, an improvement from the $46.6 million loss in the prior year period. The company significantly strengthened its cash position to $6.2 million through various private placements and equity offerings, though it continues to operate with a stockholders' deficit of $13.2 million.
Loar Holdings Inc. reported net sales of $176.2 million for the third quarter of 2026, a significant increase from $126.8 million in the prior year period. Despite higher operating income, net income for the quarter decreased to $19.6 million from $27.6 million year-over-year, primarily driven by a substantial increase in interest expense and a higher income tax provision.
Aemetis reported Q3 2026 financial results with revenue growing 49% year-over-year to $88.2 million and net income of $5.2 million. Results were significantly bolstered by $24.7 million in Section 45Z production tax credits following a favorable update to the U.S. Department of Energy's emission model for dairy RNG.
“We are pleased to report third quarter net income of $5.2 million and the continued growth of Aemetis Biogas production, supported by the updated calculation of emission rates under 45Z.”
Eric McAfee, Chairman and CEO of Aemetis
“Revenues during the third quarter of 2026 were $88.2 million, including $24.7 million of Section 45Z production tax credits. These results reflect strong execution by our California Ethanol and Dairy Renewable Natural Gas segments.”
Red River Bancshares Insider Teddy Ray Price Buys $111K of Stock
Teddy Ray Price bought 1,031 shares of Red River Bancshares Inc at $107.56 to $107.79 a share (average $107.76) in 2 transactions, worth $111K in total on Nov 4, 2026. Shares held after the trade: 66,141 (+0.2%).
Forge Nano Holdings, Inc. has completed the acquisition of HZO, Inc., a provider of protective nanocoatings for electronics. The deal combines Forge Nano's Atomic Layer Deposition (ALD) platform with HZO's high-volume Parylene and thin-film coating business and global customer base. The acquisition is intended to provide customers with a single surface engineering partner across the device lifecycle, from wafers to finished assemblies.
Counterparty
HZO, Inc.
“HZO has spent more than a decade solving a problem every electronics manufacturer has and few can solve at scale: protecting devices from the environments they live in. Their Parylene platform, their customer relationships and their production discipline are exactly what we need as our ALD technology moves from the lab to high-volume manufacturing. We are pleased to welcome the HZO team to Forge Nano.”
Paul Lichty, Chief Executive Officer of Forge Nano
“Forge Nano and HZO were built on the same conviction, that the most valuable engineering in a modern device often happens in a layer too thin to see. HZO learned how to deliver that engineering at production volume for some of the most demanding customers in the world. Forge Nano brings the atomic-scale science, the public-company platform and the capital to take it much further. Our customers will see one partner with a wider toolkit, and our people will see a company whose ambition matches th”
First Capital Signs $33.2M M&A Deal with First Bancorp of Indiana, Inc.
First Capital, Inc. (FCAP) has entered into a definitive agreement to acquire First Bancorp of Indiana, Inc. (FBPI) in an all-stock transaction valued at approximately $33.2 million. First Bancorp shareholders will receive 0.3075 shares of First Capital common stock for each share held, expanding First Capital's banking presence in Southern Indiana and Western Kentucky.
Value
$33.2M
Counterparty
First Bancorp of Indiana, Inc.
“We are extremely excited to partner with First Bancorp and further expand our presence across Southern Indiana and Western Kentucky. The expansion of our branch network across these markets will allow us to attract additional talent, build meaningful customer relationships and grow our franchise through a partnership with an organization that shares our approach to community banking.”
Chris Frederick, President and Chief Executive Officer of First Capital
“We are pleased to join First Capital’s strong franchise and believe the cultural alignment between our organizations is ideal for the next chapter for First Bancorp’s customers, employees and shareholders.”
Michael Head, President and Chief Executive Officer of First Bancorp
MMEX Resources' affiliate received approval from the Texas Commission on Environmental Quality (TCEQ) for its UltraClean Refinery North facility in Pecos County. This approval, combined with a previous approval for the South facility, enables a planned refinery complex with a processing capacity of 60,000 barrels of crude oil per day.
Microbot Medical announced that the Canadian Intellectual Property Office granted a patent for an adaptor used in its LIBERTY Endovascular Robotic System. This grant brings the company's global intellectual property portfolio to 45 issued patents and 48 pending applications, supporting its strategy for international commercialization expansion.